Here at the European Antibody Congress, we want to know what the industry is thinking and where antibody research and development is headed. So we asked you and your peers! Early in 2013 we commissioned a survey to ask exactly what you think have been, and what will be the breakthroughs in antibody and next-generation therapeutics. We asked three key questions to see where respondents thought this sector was headed.
Download and read on to see:
- What the industry thinks is the single biggest ‘Game Changer’ that has happened in the antibody and next generation technology sector in the last 12 months
- What the industry thinks is likely to be the single biggest ‘Game Changer’ in the antibody and next generation technology sector over the next 12 months
- What the industry thinks is the single biggest ‘Challenge’ still gone unsolved in the antibody and next generation technology sector
Are you interested in learning more and engaging in discussion on mAbs, ADC's, bispecifics and antibody biosimilars? Do you want to hear how these challenges are being overcome? Do you want to network with senior executives and opinion leaders from truly international antibody pioneers? Take a look at the European Antibody Congress 2013.